I am a
Home I AM A Search Login

Papers of the Week

2022 Jul-Aug

Ann Indian Acad Neurol



Serotonin Receptor agonist and Risk of Paresthesia in Migraine Patients: A Dose-Response Model-Based (Network) Meta-Analysis.


Hasan Abdi S A, Sayed S F, Bhaskar J
Ann Indian Acad Neurol. 2022 Jul-Aug; 25(4):669-675.
PMID: 36211148.


Migraine may be an important factor for paresthesia in the limbs, especially in the upper limbs. In several patients, paresthesia is responsible for a low quality of life. Treatment with the serotonin agonist may be a triggering factor for paresthesia in certain patients. Various serotonin receptor agonists are available for migraine treatment. We performed a meta-analysis of updated clinical trials of the serotonin agonist to figure out the risk of paresthesia.